BIODESIX INC (BDSX) AI Dilution Summary

The company is funding itself through cash and an at-the-market program. Estimated cash was $29,996,000 as of 2026-06-30, the same as the balance-sheet figure on that date, against estimated monthly burn of $520,667. The ATM with TD Securities (USA) LLC (TD Cowen) is authorised to $50,000,000 and has sold 3,104,455 shares since the program began, through 2026-06-30.